{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-013879","form_type":"8-K","ticker":"TECH","cik":"0000842023","company_name":"BIO-TECHNE Corp","filed_at":"2024-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.136566+00:00","generated_at":"2026-05-30T08:44:11.006511+00:00","sec_items":["2.02","5.07","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Bio-Techne Q1 revenue $289.5M (organic +4%), adj EPS $0.42; declares $0.08 dividend","bullets":["Q1 revenue $289.5M, up 5% reported (4% organic); GAAP EPS $0.21 vs $0.31; adjusted EPS $0.42 vs $0.41.","Diagnostics & Spatial Biology segment organic growth 14%; cell and gene therapy workflow solutions strong.","Dividend of $0.08 per share declared, payable Nov 22 to holders of record Nov 11.","Annual meeting: board set at 9, all director nominees elected, say-on-pay approved, KPMG ratified."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-013879","json":"https://secwatch.observer/filing/0001558370-24-013879.json","markdown":"https://secwatch.observer/filing/0001558370-24-013879.md","text":"https://secwatch.observer/filing/0001558370-24-013879.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/842023/000155837024013879/0001558370-24-013879-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/842023/000155837024013879/tech-20241025x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T08:44:11.006511+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}